Headline Closes $865 Million to Invest in Growth-Stage Tech Companies
18.9.2024 17:53:00 CEST | Business Wire | Press Release
Headline today announced Headline Global Growth IV with $865M1 of capital committed to the strategy to support companies at their Growth inflection points, Series B and beyond.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240918812241/en/
Headline's Global Growth Equity Team (Photo: Business Wire)
The Global Growth strategy has three distinct advantages: a diverse and experienced team, extensive geographic coverage, and advanced in-house built technology for sourcing (Searchlight) and analytics (DeepDive). Led by seasoned Growth investor Shalini Rao, the Growth team is committed to identifying and nurturing "Paradiesvögel"—tenacious technology founders poised for global success. Recent team additions to Headline Global Growth include Nancy Xiao, Trevor Neff, Reda Bensaid, Jake Horwitz and Austin Hack, all of whom will work out of Headline’s San Francisco and European offices.
Global Growth IV represents the evolution of growth investing at Headline. Previously, Headline primarily made investments in growth companies where Headline also had early stage exposure, backing standouts like SEMrush, Pismo, Raisin, Segment, and Fetch. With a strategy specifically crafted to capture the inflection points of Growth, Headline is expanding its universe. The fund will seek to deploy capital flexibly, with investments ranging from roughly $20 million to $70 million, mainly focusing on Headline’s core markets in the US and Europe. This approach will allow Headline to capitalize on its history of seeking to back category-leading companies in every major global tech market.
The Global Growth strategy is built on a foundation of Headline's core values and the rigor of world-class growth investing. The firm has developed advanced sourcing technologies, including the proprietary platforms, Searchlight and DeepDive, which enhance the team's ability to connect with founders and analyze business efficiencies. This technology-driven approach enables the team to engage with around 80% of companies that have raised Series A financings each month.
Headline's commitment to fostering close, long-term relationships with entrepreneurs is reflected in its investment philosophy. The firm prioritizes quality over quantity, focusing on a small number of companies to provide high levels of engagement and support.
“An investment firm ultimately builds just one product: its people,” said Rao. “And the team at Headline is united around the single objective of helping entrepreneurs succeed. To do that we will draw on our networks and track records, built up over years in both the US and Europe. But really it’s a mindset: we will do anything and everything we can to help our founders create generational companies. Just like the founders that we hope to back, we hustle and we are hungry.”
“The European tech ecosystem is still in its early stages, with lots of unrealized potential. As we have seen in the past 20 years, venture markets can shift rapidly, but technology as a whole continues growing. AI is transforming every industry and creating a massive reset,” says Christian Leybold, Founding Partner of Headline. “With a decade of track record, a proprietary technology platform, and teams on the ground in major technology hubs, Growth IV arrives at a fitting time to back some of the best private technology companies—regardless of stage.”
As Headline embarks on this next chapter, it remains dedicated to supporting innovative technology companies throughout their lifecycle. With over $4 billion in assets under management, Headline is well-positioned to drive growth and innovation in the technology sector.
The fund includes capital commitments from KfW Capital, the venture subsidiary of the German state-owned investment and development bank KfW, and the European Investment Fund (EIF). Commenting on the raise, Marjut Falkstedt, EIF Chief Executive, says: “Despite being home to world-class talent, cost-efficient companies, and groundbreaking ideas, Europe invests significantly less in venture capital compared to the United States and Asia. This funding gap not only limits our startups' ability to scale but also risks losing them to foreign markets where capital is more readily available. This is a trend that we are committed to reversing, and that is why we are happy to back Headline through the European Tech Champions Initiative.”
Christian Röhle, Head of Investment Management of KfW Capital, commented: “Headline’s $865 million growth fund is a very positive signal for the European VC ecosystem. Large-volume VC funds are indispensable to close the later-stage financing gap in the European VC market. Only large VC funds can lead large financing rounds to support the growth of promising scale-ups. In parallel to its successful closing, Headline attracted two experienced international female investment professionals as partners to its new growth fund, thereby fostering diversity in the European VC ecosystem.”
About Headline
Founded in 1998, Headline is a venture capital firm that partners with fast-growing technology teams in key geographies to make their success global. With more than $4B of assets under management, the firm invests from its network of regionally-focused early-stage funds across the US, Europe, Asia, and Latin America. Headline’s Global Growth Fund invests globally from Series B and beyond. The size and locations of these funds allow the firm to see local trends up close, meet winning founders, and lead rounds at every stage. Among the 300+ investments globally, Headline’s portfolio includes Acorns, AppFolio, ANGI (FKA Angie’s List), Brite Payments, Bumble, Fetch, Gopuff, Honeycomb, LucidLink, Mistral AI, Monta, NGINX, Raisin, Sonos, Segment, SEMrush, Staffbase, Swile.
Headline relies on the “venture capital adviser exemption” for purposes of the Investment Advisers Act of 1940. This press release announces the close of our two parallel funds. No part of this press release is intended to be, and may be relied upon, as investment advice, investment recommendation, an offer to sell, or the solicitation of any offer to buy, any security or adopt any investment strategy. No compensation was paid for any quoted remarks included in this press release. A complete list of Headline’s investments is available at headline.com/portfolio.
1 All amounts that are denominated in EUR (Euros) have been converted to USD (U.S. Dollars) using an exchange rate of 1.1087 the exchange rate as of September 9, 2024. Please note that exchange rates fluctuate, and the conversion rate at the time of actual transactions may differ.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240918812241/en/
Contacts
Media Contact:
Jacopo Luperi
Marketing & Communications, Headline
jacopo@headline.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press Release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press Release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
Grindr Nominates Three New Directors to Its Board of Directors30.4.2026 23:16:00 CEST | Press Release
Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu
The Empire State Building Celebrates 95 Years as the ‘World’s Most Famous Building’30.4.2026 22:42:00 CEST | Press Release
The Empire State Building (ESB), the “World’s Most Famous Building,” will celebrate its 95th anniversary on May 1, 2026, with new offers at the Empire State Building Observation Deck, a special birthday tower lighting display, and a slate of celebrations to honor its legacy and future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430693323/en/ The Empire State Building Celebrates 95 Years as the ‘World’s Most Famous Building’ “The Empire State Building celebrates its 95th anniversary, still the ‘World’s Most Famous Building,’ a modernized, sustainability leader as technologically advanced today as the day she was completed, and the winner of #1 Top Attraction in the United States in Tripadvisor’s Travelers’ Choice Awards for 2026,” said Anthony E. Malkin, chairman and CEO of Empire State Realty Trust. Anniversary Offerings and Experiences To mark its 95th anniversary, the Empire State Building will debut new experiences
MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis30.4.2026 22:17:00 CEST | Press Release
MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the power of the microbiome to restore immune balance, today announced that MH002, the Company’s lead rationally designed Live Biotherapeutic Product (LBP) candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate ulcerative colitis (UC). MH002 today is the most advanced LBP targeting inflammatory bowel disease (IBD)-specific mechanisms and is composed of a rationally designed microbial consortium of six well-characterized commensal strains. The FDA’s Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. The purpose is to get important drugs to patients earlier. Fast Track designation enables frequent communication with the FDA to discuss the drug's development plan and ensure collection o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom